Barry Rosen, BridgeTower Media Newswires
It is a basic principle of federal tax law that, while a taxpayer is free to organize his affairs as he chooses, once having done so, he must accept the tax consequences of his choice, whether contemplated or not. A medical group that chooses to organize as a C corporation may be forced to appreciate this principle if the Internal Revenue Service questions the reasonableness of the compensation paid to its shareholder-employees.
—————
Brinks
The United States Tax Court, in Brinks Gilson & Lione v. Commissioner, a decision issued on Feb. 10, 2016, provides professional service corporations with another reminder about the distinction between reasonable compensation, which is deductible to the corporation, and dividends to shareholders, which are not. The taxpayer in Brinks is a law firm organized and taxed as a C corporation.
Upon examination, the IRS disallowed compensation deductions for certain amounts paid to shareholders and reclassified such amounts as non-deductible dividends. Although the taxpayer agreed to the reclassification, it disputed the penalties being imposed by arguing that it had substantial authority for deducting the amounts as compensation.
—————
Independent investor test
Instead of considering various factors to assess reasonableness of compensation (such as the employee’s role in the company, a comparison with similar companies, and the character and condition of the company), the Tax Court focused on the “independent investor test.”
The independent investor test recognizes that shareholder-employees and their corporations generally have a bias toward labeling payments as compensation rather than dividends, because compensation is deductible. An independent investor who is not also an employee, however, would expect a reasonable return on his invested capital, and, therefore, would not approve of a compensation arrangement that would allow a bulk of the corporation’s earnings to be paid out as compensation without any payment of dividends.
Thus, purported compensation payments made to shareholder-employees by a corporation with significant capital that zero out the corporation’s income and leave no return on the shareholders’ capital will fail the independent investor test, meaning that the IRS may recharacterize such payments as dividends.
In Brinks, the IRS argued that payments made to shareholder-employees do not qualify as deductible compensation to the extent such payments are funded by earnings attributable to the use of the corporation’s intangible assets or other capital. The taxpayer countered by asserting that capital is not a material income-producing factor in a professional services business.
The Tax Court, however, found that the taxpayer had substantial capital, even without regard to any intangible assets (such as the firm’s reputation and client lists), because the book value of its shareholders’ equity approximated $8 million, resulting from net earnings left in the corporation in prior years.
Noting such substantial capital, the Tax Court did not believe that the shareholders, if they were not also employees, would have forgone any return on $8 million of invested capital so as to allow compensation payments that zeroed out the corporation’s book income, thus failing the independent investor test.
Since the payments failed the independent investor test, the Tax Court found that the taxpayer did not have substantial authority to support a deduction, and, therefore, upheld the penalties for mischaracterizing the payments made to the shareholder-employees.
—————
Reminder
Brinks is a reminder for C corporation professional practices that deduct amounts paid as compensation to its shareholder-employees that to completely eliminate, or come close to eliminating, its net income, especially if the shareholders have left net earnings in the corporation in prior years or otherwise have significant investment in the corporation, that the IRS may attempt to recharacterize such payments as dividends.
—————
Barry F. Rosen is the chairman & CEO of the law firm Gordon Feinblatt LLC, heads the firm’s health care practice group, and can be reached at 410-576-4224 or brosen@gfrlaw.com. Douglas Turner Coats is the chairman of Gordon Feinblatt’s tax department, and can be reached at 410-576-4002 or dcoats@gfrlaw.com.
